CTIX - more dumping today, down to 2.90 currently. Listening to last week's investor presentation, I didn't notice any obvious problem other than the FDA had apparently requested more data analysis from the Brilacidin Phase 2 prior to their giving the OK for the Phase 3.
CTIX only had $7 mil in cash at the end of Q3, so the current selloff is most likely related to an upcoming financing. Looking at the SEC filings, in Nov they had a registration related filing, so one would expect some type of financing to be announced soon.